232
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Pediatric Inflammatory CNV: A Case Series from a Tertiary Referral Centre

&
Pages 26-32 | Received 15 Sep 2018, Accepted 28 Jan 2019, Published online: 27 Feb 2019

REFERENCES

  • Sivaprasad S, Moore AT. Choroidal neovascularisation in children. Br J Ophthalmol. 2008;92:451–454. doi:10.1136/bjo.2007.124586.
  • Jabs DA, Nussenblatt RB, Rosenbaum JT, et al. Standardization of uveitis nomenclature for reporting clinical data. results of the first international workshop. Am J Ophthalmol. 2005;140:509–516. doi:10.1016/j.ajo.2005.03.057.
  • Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy: five year results from randomized clinical trials. Arch Ophthalmol. 1991;109:1109–1111. doi:10.1001/archopht.1991.01080080069030.
  • Mehta S, Hariharan L, Ho AC, Kempen JH. Peripapillary choroidal neovascularization in pars planitis. J Ophthalmic Inflamm Infect. 2013 Jan 15;3(1):1. doi:10.1186/1869-5760-3-13.
  • Spaide RF. Choroidal neovascularization in younger patients. Curr Opin Ophthalmol. 1999;(10):177–181. doi:10.1097/00055735-199906000-00005.
  • Ganesh S, Ahmed A, Biswas J. Analysis of the clinical profile and management of inflammatory choroidal neovascular membranes in uveitic eyes: a study from a tertiary referral center. Ocul Immunol Inflamm. Oct 2017;17:1–11.
  • Goshorn EB, Hoover DL, Eller AW, Friberg TR, Jarrett WH 2nd, Em S. Subretinal neovascularization in children and adolescents. J Pediatr Ophthalmol Strabismus. 1995;32:178–182.
  • Flaxel CJ, Owens SL, Mulholland B, Schwartz SD, Gregor ZJ. The use of corticosteroids for choroidal neovascularisation in young patients. Eye. 1998 Mar 1;12(2):266–272. doi:10.1038/eye.1998.62.
  • Spraul CW, Grossniklaus HE. Characteristics of drusen and Bruch’s membrane in postmortem eyes with age-related macular degeneration. Arch Ophthalmol. 1997;115:267–273. doi:10.1001/archopht.1997.01100150269022.
  • Melberg NS, Thomas MA, Burgess DB. The surgical removal of subfoveal choroidal neovascularization. ingrowth site as a predictor of visual outcome. Retina. 1996;16:190–195. doi:10.1097/00006982-199616030-00002.
  • Rishi P, Gupta A, Rishi E, Shah BJ. Choroidal neovascularization in 36 eyes of children and adolescents. Eye (Lond). 2013;27:1158–1168. doi:10.1038/eye.2013.155.
  • Giansanti F, Virgili G, Varano M, et al. Photodynamic therapy for choroidal neovascularization in pediatric patients. Retina. 2005;25:590–596. doi:10.1097/00006982-200507000-00009.
  • Lin CJ, Hwang JF, Chen YT, Chen SN. The effect of intravitreal bevacizumab in the treatment of coats disease in children. Retina. 2010;30:617–622. doi:10.1097/IAE.0b013e3181c2e0b7.
  • Mititelu M, Chaudhary KM, Lieberman RM An evidence-based meta-analysis of vascular endothelial growth factor inhibition in pediatric retinal diseases: part 1. Retinopathy of prematurity. J Pediatr Ophthalmol Strabismus. 2012;49:332–340. doi:10.3928/01913913-20120821-03
  • Kozak I, Mansour A, Diaz RI, et al.. Outcomes of treatment of pediatric choroidal neovascularization with intravitreal antiangiogenic agents: the results of the KKESH international collaborative retina study group. Retina. Oct 2014;34(10):2044–2052. doi:10.1097/IAE.0000000000000200.
  • Kohly RP, Muni RH, Kertes PJ, Lam WC. Management of pediatric choroidal neovascular membranes with intravitreal anti-VEGF agents: a retrospective consecutive case series. Can J Ophthalmol. 2011;46:46–50. doi:10.1016/j.jcjo.2011.07.008.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.